COVID-19 BREATHALYZER CO-CREATED BY VERBECK RESEARCH GROUP APPROVED BY FDA | Department of Chemistry
May 12, 2022

COVID-19 BREATHALYZER CO-CREATED BY VERBECK RESEARCH GROUP APPROVED BY FDA

Congratulations to Dr. Guido Verbeck and his research group! The FDA recently granted Emergency Use Authorization to a COVID-19 breathalizer created by Dr. Verbeck's research lab, in collaboration with InspectIR Systems, located in Frisco, TX.

You can learn more about the authorization and breathalyzer by reading the UNT News article and the North Texas Daily article.

*Photo courtesy of the North Texas Daily article.